The best indicator for Zebra Technologies (ZBRA)
We backtested 20 indicators across daily, weekly and hourly charts on real Zebra Technologies (ZBRA) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
WaveTrend (8/6/4)
On the daily chart, this is the strongest risk-adjusted edge we found for Zebra Technologies (ZBRA) over ~34.8 years — trailing buy-and-hold by 3.1% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | WaveTrend (8/6/4) ✓ | Daily | 9.2% | 0.44 | -69.1% | 69.1% | 136 | -3.1% |
| 2 | EMA 20/50 Cross ✓ | Weekly | 8.7% | 0.43 | -59.5% | 60.0% | 15 | -3.6% |
| 3 | Stochastic ✓ | Daily | 7.0% | 0.39 | -52.3% | 69.3% | 179 | -5.3% |
| 4 | CCI ✓ | Daily | 7.2% | 0.39 | -64.2% | 74.7% | 166 | -5.2% |
| 5 | SMA 50/200 Cross ✓ | Daily | 6.4% | 0.36 | -63.1% | 52.0% | 25 | -6.0% |
| 6 | Williams %R ✓ | Daily | 6.1% | 0.35 | -64.4% | 68.9% | 222 | -6.2% |
| 7 | Bollinger Mean-Reversion ✓ | Weekly | 5.6% | 0.35 | -38.5% | 68.8% | 32 | -6.7% |
| 8 | Holy Grail Confluence ✓ | Daily | 5.5% | 0.34 | -64.0% | 70.9% | 55 | -6.9% |
| 9 | Stochastic ✓ | Weekly | 5.4% | 0.34 | -54.2% | 77.4% | 31 | -6.9% |
| 10 | ADX / DMI ✓ | Weekly | 5.2% | 0.34 | -68.8% | 55.6% | 45 | -7.1% |
| 11 | RSI Mean-Reversion ✓ | Daily | 4.6% | 0.33 | -58.0% | 72.2% | 54 | -7.8% |
| 12 | Williams %R ✓ | Weekly | 4.9% | 0.31 | -54.2% | 73.2% | 41 | -7.4% |
| 13 | EMA 20/50 Cross ✓ | Daily | 4.6% | 0.3 | -77.3% | 37.5% | 80 | -7.7% |
| 14 | Donchian Breakout ✓ | Weekly | 4.4% | 0.3 | -68.2% | 44.8% | 29 | -7.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Zebra Technologies (ZBRA), WaveTrend (8/6/4) on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.